In 2016, Bailey et al. reported 5% germline mutations and 12% somatic mutations in the BRCA pathway (BRCA1, BRCA2, ATM and PALB2) through whole genome sequencing of 456 pancreatic cancer [8]. This evidence concerns the gene PALB2 and pancreatic neoplasm.